The Paws-Solidation Era: How 2025 Became the Record-Breaking Year for Pet Care M&A As 2025 comes to a close, the financial landscape of the pet care industry has been fundamentally reshaped by a tidal wave of mergers and acquisitions. What began as a post-pandemic stabilization period in early 2024 transformed into a historic consolidation frenzy, with the sector recording a staggering 532 transactions
Uncover the latest developments among S&P500 stocks in today's session. Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Ron Baron Says Tesla Could 5X And SpaceX 10X — Says Musk Is 'Like Da Vinci' Billionaire investor Ron Baron is up big on his investments in Tesla and SpaceX and he doesn't plan on selling.
Meta Platforms, S&P Global And A Health Care Stock: CNBC's 'Final Trades' Stephen Weiss of Short Hills Capital Partners recommended buying Meta Platforms, which is down almost 20% from the high.
Why Idexx Laboratories Stock Surged by Almost 15% Today Investors were barking for some shares thanks to a better-than-expected earnings report.
Stay informed with the top movers within the S&P500 index on Monday. Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.
These S&P500 stocks have an unusual volume in today's session Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Exploring the top movers within the S&P500 index during today's session. Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
How Idexx Laboratories Business Shook Off Bears And Hit A Record Idexx Laboratories catapulted to a record high Monday after the vet diagnostics outlet beat quarterly forecasts.
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook Idexx stock gains after Q3 earnings and revenue beat expectations, driven by strong CAG growth and raised 2025 earnings and sales guidance.
Discover the top S&P500 movers in Monday's pre-market session. Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
IDEXX LABORATORIES INC (NASDAQ:IDXX) Surpasses Q3 2025 Estimates and Raises Full-Year Outlook IDEXX Labs Q3 2025 results beat estimates with strong revenue and EPS growth. The veterinary diagnostics leader also raised its full-year outlook.
